Abstract:Corneal transplantation is a critical surgical procedure aimed at restoring vision in patients with corneal blindness or severe damage. This review focuses on secondary glaucoma, a significant postoperative complication, with the primary objective of providing a comprehensive analysis of its pathophysiology, risk factors, diagnostic challenges, and therapeutic approaches. Unlike other reviews, this work emphasizes the interplay between inflammatory responses, corticosteroid use, and structural changes in the eye that lead to elevated intraocular pressure (IOP) after transplantation. A comprehensive review of the literature was conducted, including studies on postcorneal transplantation glaucoma, to highlight both clinical outcomes and the efficacy of current management strategies. Key findings indicate that medical treatments, such as prostaglandin analogs and beta-blockers, are effective for IOP control in the early stages, while surgical interventions, like trabeculectomy, are often necessary for more advanced cases. Diagnostic challenges, such as the difficulty of accurate IOP measurement posttransplant, are underscored, along with the importance of advanced imaging techniques for the early detection of optic nerve damage. The pathophysiology of secondary glaucoma involves a complex interaction of postsurgical inflammation, steroid-induced complications, and anatomical changes that hinder aqueous humor outflow. Diagnosis requires a combination of tonometry, gonioscopy, and imaging technologies. Management strategies range from pharmacological treatments to surgical options, with a critical focus on balancing IOP control and minimizing risks to graft survival. Clinically, these findings highlight the need for proactive and tailored management of IOP in corneal transplant patients to preserve both graft function and long-term visual outcomes. Future research should focus on improving diagnostic accuracy, developing less invasive surgical techniques, and exploring personalized medicine approaches, including genetic profiling and targeted therapies.

Secondary Glaucoma in the Context of Retinal Disease

Challenges of Secondary Glaucoma Management Following Congenital Cataract Surgery, Penetrating Keratoplasty and Vitreoretinal Surgery

A Review of the Surgical Management of Neovascular Glaucoma

Clinical characteristics of secondary glaucoma associated with posterior segment disease

Secondary Neovascular Glaucoma in the Course of Diabetes in a Kidney Transplant Recipient: Case Report and Review of the Literature

Secondary Glaucoma Following Corneal Transplantation: A Comprehensive Review of Pathophysiology and Therapeutic Approaches

The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy

Glaucoma: the retina and beyond

Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis

The Management of Secondary Glaucoma in Nanophthalmic Patients

Schwartz-Matsuo syndrome: An important cause of secondary glaucoma

Glaucoma Secondary to Systemic Lupus Erythematosus.

Diagnosis and management of secondary glaucoma: Dural fistula and intracranial hypotension

Current approaches in neovascular glaucoma

Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action

[Glaucoma--neurodegenerative disease]

Clinical analysis of secondary glaucoma associated with ocular trauma

The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion

Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma

Retrospective Clinical Analysis of 118 Cases with Malignant Glaucoma

Update in Genetics and Surgical Management of Primary Congenital Glaucoma